Skip to main content
Clinical Trials/NCT07405281
NCT07405281
Not yet recruiting
Not Applicable

A Multicenter, Prospective Clinical Randomized Controlled Study of the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain

Second Affiliated Hospital, School of Medicine, Zhejiang University0 sites208 target enrollmentStarted: March 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
208
Primary Endpoint
AOFAS score

Overview

Brief Summary

Investigators recruited 208 patients with acute ankle sprain who were from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University, School of Medicine from January 2026 to November 2028. Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years.

Detailed Description

In baseline, 208 patients with i acute ankle sprain were recruited from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University School of Medicine from January 2026 to December 2028, and were followed up after 3 years.

Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years. The Hyperbaric oxygen group treatment was administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen was inhaled for 40 minutes (20 minutes of oxygen inhalation, 5-minute rest, 20 minutes of oxygen inhalation, decompression), once daily for 14 consecutive days. The control group treatment at an atmospheric pressure of 1.4 ATA, inhaling 21% oxygen by volume. Oxygen inhalation schedule: 40 minutes (inhale oxygen for 20 minutes, rest for 5 minutes, inhale oxygen for 20 minutes, decompression), once a day for 14 consecutive days.

Two person analyzed the above data, and record abnormal results.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Unilateral ankle sprain;
  • Swelling, bruising, and pain at the site of the sprain;
  • Injury occurring within 72 hours;
  • MRI examination clearly shows ligament damage.

Exclusion Criteria

  • X-ray shows ankle fracture;
  • Ankle has skin lesions or skin diseases;
  • History of lower limb and pelvic surgery;
  • Obvious neurological or psychiatric disorders that may interfere with assessment;
  • Severe ligament injuries or joint instability requiring surgical treatment;
  • Previous ankle injuries, persistent pain or functional limitations;
  • Pneumothorax, severe emphysema, active bleeding, or other diseases with contraindications for hyperbaric oxygen therapy.

Arms & Interventions

hyperbaric oxygen group

Experimental

The treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation.

Intervention: hyperbaric oxygen therapy (Other)

non hyperbaric oxygen group

Sham Comparator

The treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%

Intervention: non Hyperbaric Oxygen Therapy (Other)

Outcomes

Primary Outcomes

AOFAS score

Time Frame: 3 years

Improvement of American Orthopaedic Foot \& Ankle Society Score (AOFAS scores)in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100, higher scores mean a better outcome.

Baird-Jackson ankle score

Time Frame: 3 years

Improvement of Baird-Jackson Ankle Evaluation Score(Baird-Jackson ankle scores) in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100., higher scores mean a better outcome.

Secondary Outcomes

  • pain scores(3 years)
  • ankle swelling(3 years)
  • high-frequency ultrasound findings(3 years)
  • Ankle MRI(3 years)
  • patient's overall evaluation of treatment (PGIC)(3 years)
  • HAMA scale score(3 years)

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials